Rosenblatt analyst Steve Frankel reiterates Dolby Laboratories (NYSE:DLB) with a Buy and maintains $90 price target.
Rosenblatt Reiterates Buy on Dolby Laboratories, Maintains $90 Price Target
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.